Author:
Lakdawalla Darius N.,Phelps Charles E.,Nguyen Hong-Hanh
Reference37 articles.
1. Orphan drugs-the regulatory environment;Franco;Drug Discov Today,2013
2. A compilation of national plans, policies and government actions for rare diseases in 23 countries;Khosla;Intractable Rare Dis Res,2018
3. Rare diseases, orphan drugs, and their regulation in Asia: current status and future perspectives;Song;Intractable Rare Dis Res,2012
4. Policy measures taken in Japan to improve the quality of life for patients with rare/intractable diseases;Song;Expert Opin Orphan Drugs,2019
5. Does an orphan drug policy make a difference in access? A comparison of Canada and Australia;Lexchin;Regul Pharm Ind,2020